The DOI matches its Crossref record; 774 of the 774 references it cites were found in a registry or an index.
Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance
Abstract
A number of therapeutic drugs with different structures and mechanisms of action have been reported to undergo metabolic activation by Phase I or Phase II drug-metabolizing enzymes. The bioactivation gives rise to reactive metabolites/intermediates, which readily confer covalent binding to various target proteins by nucleophilic substitution and/or Schiff's base mechanism. These drugs include analgesics (e.g., acetaminophen), antibacterial agents (e.g., sulfonamides and macrolide antibiotics), anticancer drugs (e.g., irinotecan), antiepileptic drugs (e.g., carbamazepine), anti-HIV agents (e.g., ritonavir), antipsychotics (e.g., clozapine), cardiovascular drugs (e.g., procainamide and hydralazine), immunosupressants (e.g., cyclosporine A), inhalational anesthetics (e.g., halothane), nonsteroidal anti-inflammatory drugs (NSAIDSs) (e.g., diclofenac), and steroids and their receptor modulators (e.g., estrogens and tamoxifen). Some herbal and dietary constituents are also bioactivated to reactive metabolites capable of binding covalently and inactivating cytochrome P450s (CYPs). A number of important target proteins of drugs have been identified by mass spectrometric techniques and proteomic approaches. The covalent binding and formation of drug-protein adducts are generally considered to be related to drug toxicity, and selective protein covalent binding by drug metabolites may lead to selective organ toxicity. However, the mechanisms involved in the protein adduct-induced toxicity are largely undefined, although it has been suggested that drug-protein adducts may cause toxicity either through impairing physiological functions of the modified proteins or through immune-mediated mechanisms. In addition, mechanism-based inhibition of CYPs may result in toxic drug-drug interactions. The clinical consequences of drug bioactivation and covalent binding to proteins are unpredictable, depending on many factors that are associated with the administered drugs and patients. Further studies using proteomic and genomic approaches with high throughput capacity are needed to identify the protein targets of reactive drug metabolites, and to elucidate the structure-activity relationships of drug's covalent binding to proteins and their clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 774
Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs
Yamreudeewong, W., DeBisschop, M., Martin, L. G., & Lower, D. L. (2003) · Drug Safety · doi:10.2165/00002018-200326060-00004 · Cited by 106
Polymorphisms in UDP Glucuronosyltransferase Genes: Functional Consequences and Clinical Relevance
Mackenzie, P. I., Miners, J. O., & McKinnon, R. A. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.129 · Cited by 106
Lillibridge, J. H., Liang, B. H., Kerr, B. M., Webber, S., Quart, B. D., Shetty, B. V., & Lee, C. A. (1998) · PubMed · Cited by 106
The Clinical Spectrum of Jin Bu Huan Toxicity
Horowitz, R. S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.8.899 · Cited by 105
Covalent Binding of Xenobiotics to Specific Proteins in the Liver
Pumford, N. R., Halmes, N. C., & Hinson, J. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709037572 · Cited by 105
CaJacob, C. A., Chan, W. K., Shephard, E. A., & de Montellano, P. R. O. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37333-2 · Cited by 104
Effects of erythromycin on hepatic drug-metabolizing enzymes in humans
Larrey, D. G., Funck‐Brentano, C., Breil, P., Vitaux, J., Theodore, C., Babany, G., & Pessayre, D. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90626-3 · Cited by 104
Metabolic activation of toxins: tissue-specific expression and metabolism in target organs.
Pelkonen, O., & Raunio, H. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s4767 · Cited by 104
Kessler, D. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006083422309 · Cited by 104
Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo*
Mitra, A., Thummel, K. E., Kalhorn, T. F., Kharasch, E. D., Unadkat, J. D., & Slattcry, J. T. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90176-0 · Cited by 104
Kassahun, K., Farrell, K., & Abbott, F. S. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07155-7 · Cited by 104
Jae Wook Ko, Desta, Z., Soukhova, N. V., et al. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00175.x · Cited by 103
Wikberg, T., Vuorela, A., Ottoila, P., & Taskinen, J. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07341-6 · Cited by 103
The mechanism of bioactivation and antigen formation of amodiaquine in the rat
Harrison, A. C., Kitteringham, N. R., Clarke, J. B., & Park, B. K. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90198-r · Cited by 103
Madden, S. F., Woolf, T. F., Pool, W. F., & Park, B. K. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90342-t · Cited by 103
Prueksaritanont, T., Ma, B., Tang, C., Meng, Y., Assang, C., Lü, P., Reider, P. J., Lin, J. H., & Baillie, T. A. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00903.x · Cited by 102
Allergic adverse reactions to sulfonamides
Choquet‐Kastylevsky, G., Vial, T., & Descotes, J. (2002) · Current Allergy and Asthma Reports · doi:10.1007/s11882-002-0033-y · Cited by 102
Zheng, S. S., Yang, H., Zhang, S., Wang, X., Yu, L., Lu, J., & Li, J. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1997)27+<106::aid-jcb17>3.0.co;2-l · Cited by 102
Resolution of human mercapt‐ and nonmercaptalbumin by high‐performance liquid chromatography
Sogami, M., NAGOKA, S., ERA, S., HONDA, M., & Noguchi, K. (1984) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1984.tb00933.x · Cited by 101
Genetic predisposition to drug-induced hepatotoxicity
Larrey, D. G., & Pageaux, G. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80492-8 · Cited by 101
On the Diversity of Oxidative Bioactivation Reactions on Nitrogen- Containing Xenobiotics
Kalgutkar, A. S. S., Dalvie, D., O’Donnell, J. P., Taylor, T., & Sahakian, D. C. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337360 · Cited by 101
Seitz, S., Kretz-Rommel, A., Elferink, R. P. J. O., & Boelsterli, U. A. (1998) · Chemical Research in Toxicology · doi:10.1021/tx970203+ · Cited by 101
Melet, A., Assrir, N., Jean, P., López-García, M. P., Marques‐Soares, C., Jaouen, M., Dansette, P. M., Sari, M., & Mansuy, D. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00548-9 · Cited by 100
Mycophenolate mofetil: A unique immunosuppressive agent
Hood, K. A., & Zarembski, D. G. (1997) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/54.3.285 · Cited by 99
Pumford, N. R., Hinson, J. A., Potter, D. W., Rowland, K. L., Benson, R. W., & Roberts, D. W. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23630-8 · Cited by 98
A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein
Pumford, N. R., Martin, B. M., & Hinson, J. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91881-p · Cited by 98
Immunochemical detection of acetaminophen-bound liver proteins
Bartolone, J. B., Sparks, K. J., Cohen, S. D., & Khairallah, E. A. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90069-4 · Cited by 98
Hypersensitivity Myocarditis Associated with Ephedra Use
Zaacks, S. M., Klein, L. W., Tan, C. D., Rodríguez, E. R., Leikin, J. B., & Leikin, J. B. (1999) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-100102440 · Cited by 98
Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
Ebner, T., Heinzel, G., Prox, A., Beschke, K., & Wachsmuth, H. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15038-6 · Cited by 98
Pirmohamed, M., Madden, S. F., & Park, B. K. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631030-00005 · Cited by 97
Cutaneous manifestations of antiretroviral therapy
Ward, H. A., Russo, G., & Shrum, J. P. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.119105 · Cited by 97
Clinical Experience with Adverse Reactions to Trimethoprim-Sulfamethoxazole
Frisch, J. M. (1973) · The Journal of Infectious Diseases · doi:10.1093/infdis/128.supplement_3.s607 · Cited by 97
Pirmohamed, M., Kitteringham, N. R., Guenthner, T. M., Breckenridge, A. M., & Park, B. K. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90696-g · Cited by 97
Pharmacology of systemic analgesics
Camu, F., & Vanlersberghe, C. (2002) · Best practice & research. Clinical anaesthesiology · doi:10.1053/bean.2002.0262 · Cited by 97
Fujisawa, Y., Sakamoto, M., Matsushita, M., Fujita, T., & Nishioka, K. (2000) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2000.tb02566.x · Cited by 97
Spaldin, V., Madden, S. F., Pool, W. F., Woolf, T. F., & Park, B. K. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04316.x · Cited by 96
Pharmacokinetics and Biotransformation of Mirtazapine in Human Volunteers
Delbressine, L. P. C., Moonen, M., Kaspersen, F. M., Wagenaars, G. N., Jacobs, P., Timmer, C., Paanakker, J. E., van Hal, H., & Voortman, G. (1998) · Clinical Drug Investigation · doi:10.2165/00044011-199815010-00006 · Cited by 96
Enzyme-Induction Dependent Bioactivation of Troglitazone and Troglitazone Quinone In Vivo
Tettey, J. N. A., Maggs, J. L., Rapeport, G., Pirmohamed, M., & Park, B. K. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0001981 · Cited by 96
Bourdi, M., Demady, D. R., Martin, J. L., Jabbour, S. K., Martin, B. M., George, J. W., & Pohl, L. R. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.0060 · Cited by 96
Hepatic Disposition of Electrophilic Acyl Glucuronide Conjugates
Sallustio, B. C., Sabordo, L., Evans, A. M., & Nation, R. L. (2000) · Current Drug Metabolism · doi:10.2174/1389200003339153 · Cited by 96
Sugiyama, Y., Kato, Y., & Chu, X. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051078 · Cited by 95
Koyama, E., Chiba, K., Tani, M., & Ishizaki, T. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36731-x · Cited by 95
Levodopa Is Toxic to Dopamine Neurons in an in Vitro but Not an in Vivo Model of Oxidative Stress
Mytilineou, C., Walker, R. H., JnoBaptiste, R., & Olanow, C. W. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042267 · Cited by 95
Metabolism and excretion of tolcapone, a novel inhibitor of catechol‐O‐methyltransferase
Jorga, K. M., Fotteler, B., Heizmann, P., & Gasser, R. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00036.x · Cited by 94
Pumford, N. R., Hinson, J., Benson, R. W., & Roberts, D. W. (1990) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(90)90174-s · Cited by 94
D, M. F. M., Dünner, D. L., Greist, J. H., Preskorn, S., Trivedi, M. H., Zajecka, J., & Cohen, M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0603 · Cited by 94
Rettie, A. E., Sheffels, P. R., Korzekwa, K. R., Gonzalez, F. J., Philpot, R. M., & Baillie, T. A. (1995) · Biochemistry · doi:10.1021/bi00024a013 · Cited by 94
Free Radical Intermediates of Phenytoin and Related Teratogens
Parman, T., Chen, G., & Wells, P. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25079 · Cited by 93
Koenigs, L. L., Peter, R. M., Hunter, A. P., Haining, R. L., Rettie, A. E., Friedberg, T., Pritchard, M. P., Shou, M., Rushmore, T. H., & Trager, W. F. (1999) · Biochemistry · doi:10.1021/bi9823030 · Cited by 92
Uetrecht, J. (1990) · Critical Reviews in Toxicology · doi:10.3109/10408449009089863 · Cited by 92
Hepatitis after the use of germander, a herbal remedy.
Laliberté, L., & Villeneuve, J. (1996) · PubMed · Cited by 91
de Berardinis, V., Moulis, C., Maurice, M., Beaune, P. H., Pessayre, D., Pompon, D., & Loeper, J. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.3.542 · Cited by 91
Autoantibodies against Cytochromes P450: Role in Human Diseases
Beaune, P. H., Pessayre, D., Dansette, P. M., Mansuy, D., & Manns, M. P. (1994) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60175-1 · Cited by 90
Chu, X., Kato, Y., Ueda, K., Suzuki, H., Niinuma, K., Tyson, C. A., Weizer, V., Dabbs, J. E., Froehlich, R., Green, C. E., et al. (1998) · PubMed · Cited by 90
Oral Contraceptives and Cancer
Vecchia, C. L., Altieri, A., Franceschi, S., & Tavani, A. (2001) · Drug Safety · doi:10.2165/00002018-200124100-00003 · Cited by 90
Koopmans, P. P., van der Ven, A. J. A. M., Vree, T. B., & van der Meer, J. W. M. (1995) · AIDS · doi:10.1097/00002030-199503000-00001 · Cited by 90
N-acetyltransferases: Pharmacogenetics and clinical consequences of polymorphic drug metabolism
Spielberg, S. P. (1996) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353477 · Cited by 90
Cuttle, L., Munns, A. J., Hogg, N. A., Scott, J. R., Hooper, W. D., DICKINSON, R. G., & Gillam, E. M. J. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15168-9 · Cited by 90
Bourdi, M., Tinel, M., Beaune, P. H., & Pessayre, D. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10602-0 · Cited by 90
Prediction of a new drug's potential to cause idiosyncratic reactions.
Uetrecht, J. (2001) · PubMed · Cited by 90
Drug treatment of Parkinson’s disease
Drukarch, B., & Muiswinkel, F. L. V. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00340-8 · Cited by 89
Human‐liver cytochromes P‐450 expressed in yeast as tools for reactive‐metabolite formation studies
Garcia, M., Dansette, P. M., Valadon, P., Amar, C., Beaune, P. H., Guengerich, F. P., & Mansuy, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17752.x · Cited by 89
Prostaglandin synthetase catalyzed activation of paracetamol
Moldéus, P., Andersson, B. S., Rahimtula, A. D., & Berggren, M. I. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90029-6 · Cited by 89
Boelsterli, U. A. (1993) · Drug Metabolism Reviews · doi:10.3109/03602539308993981 · Cited by 89
The use of mycophenolate mofetil suspension in pediatric renal allograft recipients
Bunchman, T. E., Navarro, M., Broyer, M., Sherbotie, J., Chavers, B. M., T�nshoff, B., Birk, P. E., Lerner, G. R., Lirenman, D. S., Greenbaum, L., et al. (2001) · Pediatric Nephrology · doi:10.1007/s004670100006 · Cited by 89
Levodopa Toxicity and Apoptosis
Melamed, E., Offen, D., Shirvan, A., Djaldetti, R., Barzilai, A., & Ziv, I. (1998) · Annals of Neurology · doi:10.1002/ana.410440722 · Cited by 88
Identification of a 54-kDa Mitochondrial Acetaminophen-Binding Protein as Aldehyde Dehydrogenase
Landin, J. S., Cohen, S. D., & Khairallah, E. A. (1996) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(96)80036-6 · Cited by 88
Stiborová, M. (2002) · Carcinogenesis · doi:10.1093/carcin/23.4.617 · Cited by 88
Metabolism of Anxiolytics and Hypnotics: Benzodiazepines, Buspirone, Zoplicone, and Zolpidem
Chouinard, G., Lefko-Singh, K., & Teboul, E. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006943009192 · Cited by 87
The Structure and Function of the UDP-Glucuronosyltransferase Gene Family
Burchell, B., Brierley, C. H., Monaghan, G., & Clarke, D. J. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60758-9 · Cited by 87
Amacher, D. E., Schomaker, S., & Retsema, J. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1186 · Cited by 87
Chronic hepatitis induced by Jin Bu Huan
Picciotto, A., Campo, N., Brizzolara, R., Giusto, R., Guido, G., Sinelli, N., Lapertosa, G., & Celle, G. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80217-1 · Cited by 87
Eling, T. E., Mason, R. P., & Sivarajah, K. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89636-3 · Cited by 86
Active Efflux of CPT-11 and Its Metabolites in Human KB-Derived Cell Lines
Chu, X., Suzuki, H., Ueda, K., Kato, Y., Akiyama, S., & Sugiyama, Y. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38014-0 · Cited by 86
Three‐dimensional structure and actions of immunosuppressants and their immunophilins
Braun, W. A., Kallen, J. A., Mikol, V., Walkinshaw, M. D., & Kurt Wüthrich, A. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.1.7529736 · Cited by 86
Anaphylactoid and Anaphylactic Reactions Hazards of β-Blockers
Lang, D. M. (1995) · Drug Safety · doi:10.2165/00002018-199512050-00002 · Cited by 86
First-pass metabolism of imipramine and desipramine: Impact of the sparteine oxidation phenotype
Brøsen, K., & Gram, L. F. (1988) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1988.50 · Cited by 86
Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine
Jewell, H., Maggs, J. L., Harrison, A. C., O’Neill, P. M., Ruscoe, J. E., & Park, B. K. (1995) · Xenobiotica · doi:10.3109/00498259509061845 · Cited by 86
The 1- and 2-electron oxidation of acetaminophen catalyzed by prostaglandin H synthase.
Potter, D. W., & Hinson, J. A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75736-6 · Cited by 85
Kubow, S. J., & Wells, P. G. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11254-6 · Cited by 85
von Moltke, L. L., Durol, A. L. B., Duan, S. X., & Greenblatt, D. J. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000125 · Cited by 85
Diphenylhydantoin teratogenicity in rats
Harbison, R. D., & BECKER, B. A. (1972) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(72)90168-8 · Cited by 85
Analgesic use and chronic renal failure: A critical review of the epidemiologic literature
McLaughlin, J. K., Lipworth, L. P., Chow, W., & Blot, W. J. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00043.x · Cited by 85
Wright, A. M., Bempong, J., Kirby, M. L., Barlow, R. L., & Bloomquist, J. R. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01551-5 · Cited by 85
Tang, W., Borel, A. G., Fujimiya, T., & Abbott, F. S. (1995) · Chemical Research in Toxicology · doi:10.1021/tx00047a006 · Cited by 84
Bartolone, J. B., Birge, R. B., Bulera, S. J., Bruno, M. K., Nishanian, E. V., Cohen, S. D., & Khairallah, E. A. (1992) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(92)90004-c · Cited by 84
Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells
Yamamoto, Y., Yamazaki, H., Ikeda, T., Watanabe, T., Iwabuchi, H., Nakajima, M., & Yokoi, T. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.2.155 · Cited by 84
Chinese Herbal Medicine Induced Acute Renal Failure
Abt, A. B., Oh, J. Y., Huntington, R. A., & Burkhart, K. K. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430020103013 · Cited by 84
Hinson, J., Pohl, L. R., & Gillette, J. R. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90111-5 · Cited by 84
Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes
Shishido, S., Koga, H., Harada, M., Kumemura, H., Hanada, S., Taniguchi, E., Kumashiro, R., Ohira, H., Satô, Y., Namba, M., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50014 · Cited by 84
Inhibitory effects of verapamil and diltiazem on simvastatin metabolism in human liver microsomes
Yeo, K. R., & Yeo, W. W. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01386.x · Cited by 83
Cresol Isomers: Comparison of Toxic Potency in Rat Liver Slices
Thompson, D. C., Perera, K., Fisher, R., et al. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1048 · Cited by 83
Hargus, S. J., Martin, B. M., George, J. W., & Pohl, L. R. (1995) · Chemical Research in Toxicology · doi:10.1021/tx00050a001 · Cited by 83
Thalidomide Stimulates T Cell Responses and Interleukin 12 Production in HIV-Infected Patients
Haslett, P. A. J., Klausner, J. D., Makonkawkeyoon, S., Moreira, A. L., Metatratip, P., Boyle, B., Kunachiwa, W., Maneekarn, N., Vongchan, P., Corral, L. G., et al. (1999) · AIDS Research and Human Retroviruses · doi:10.1089/088922299310269 · Cited by 83
The Toxicity of Metabolites of Sodium Valproate in Cultured Hepatocytes
Kingsley, E., Gray, P. D., Tolman, K. G., & Tweedale, R. (1983) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1983.tb02722.x · Cited by 83
Nelfinavir Mesylate: A Protease Inhibitor
Pai, V. B., & Nahata, M. C. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18089 · Cited by 83
Identification of acetaminophen polymerization products catalyzed by horseradish peroxidase.
Potter, D. W., Miller, D. W., & Hinson, J. A. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39003-8 · Cited by 82
Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
Tinel, M., Descatoire, V., Larrey, D. G., Loeper, J., Labbe, G., Lettéron, P., & Pessayre, D. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22274-1 · Cited by 82
Furst, S. M., & Uetrecht, J. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90279-6 · Cited by 81
Qiu, Y., Burlingame, A. L., & Benet, L. Z. (1998) · PubMed · Cited by 81
Current perspectives on oral contraceptive use
Burkman, R. T., Collins, J. A., SHULMAN, L. P., & Williams, J. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.117416 · Cited by 80
Immune mechanisms in tienilic acid associated hepatotoxicity.
Neuberger, J., & Williams, R. L. (1989) · Gut · doi:10.1136/gut.30.4.515 · Cited by 80
Hepatitis associated with Chinese herbs
Mcrae, C., Agarwal, K., Mutimer, D. J., & Bassendine, M. F. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200205000-00015 · Cited by 80
Bolze, S., Bromet, N., Gay-Feutry, C., Massière, F., Boulieu, R., & Hulot, T. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.4.404 · Cited by 79
Riley, R., Maggs, J. L., Lambert, C., Kitteringham, N. R., & Park, B. K. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb05298.x · Cited by 79
de Vries, J. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90622-5 · Cited by 79
Olson, D. P., Scadden, D. T., D’Aquila, R. T., & Pasquale, M. P. D. (2002) · AIDS · doi:10.1097/00002030-200209060-00005 · Cited by 79
Liebler, D. C. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s113 · Cited by 78
Chen, W., Shockcor, J. P., Tonge, R., Hunter, A. S., Gartner, C. G., & Nelson, S. D. (1999) · Biochemistry · doi:10.1021/bi990125k · Cited by 78
Funck‐Brentano, C., Becquemont, L., Kroemer, H. K., Bühl, K., Knebel, N. G., Eichelbaum, M. F., & Jaillon, P. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.26 · Cited by 77
Prussick, R. B. (1992) · Archives of Dermatology · doi:10.1001/archderm.1992.01680120082007 · Cited by 77
Cribb, A. E., Nuss, C. E., Alberts, D. W., Lamphere, D. B., Grant, D. M., Grossman, S. J., & Spielberg, S. P. (1996) · Chemical Research in Toxicology · doi:10.1021/tx950167j · Cited by 77
In Vitro and In Vivo Studies on the Disposition of Mirtazapine in Humans
Dahl, M., Voortman, G., Alm, C., Elwin, C., Delbressine, L. P. C., Vos, R. M. E., Bogaards, J. J. P., & Bertilsson, L. (1997) · Clinical Drug Investigation · doi:10.2165/00044011-199713010-00005 · Cited by 77
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
Coleman, M. D., Breckenridge, A., & Park, B. K. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03517.x · Cited by 76
Third Generation Anticonvulsants in Bipolar Disorder
Yatham, L. N., Kusumakar, V., Calabrese, J. R., Rao, R. V., Scarrow, G., & Kroeker, G. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0402 · Cited by 76
Robin, M. A., Maratrat, M., Roy, M. L., Breton, F. P. L., Bonierbale, E., Dansette, P. M., Ballet, F., Mansuy, D., & Pessayre, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118936 · Cited by 76
Neubert, R. T., Hinz, N., Thiel, R., & Neubert, D. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02290-2 · Cited by 76
Hinson, J. A. (2000) · Toxicological Sciences · doi:10.1093/toxsci/53.2.467 · Cited by 76
Kretz-Rommel, A., & Boelsterli, U. A. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08441-7 · Cited by 76
Levodopa neurotoxicity: Experimental studies versus clinical relevance
Jenner, P. G., & Brin, M. F. (1998) · Neurology · doi:10.1212/wnl.50.6_suppl_6.s39 · Cited by 76
Christ, D. D., Satoh, H., Kenna, J. G., & Pohl, L. R. (1988) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06888-6 · Cited by 76
Goodman, Z. D. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00011-9 · Cited by 75
Teyssier, C., Guenot, L., Suschetet, M., & Siess, M. H. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)11821-1 · Cited by 74
Kassahun, K., Hu, P. L., Grillo, M. P., Davis, M. R., Jin, L., & Baillie, T. A. (1994) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)90014-0 · Cited by 74
Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives
Tinel, M., Belghiti, J., Descatoire, V., Amouyal, G., Lettéron, P., Genève, J., Larrey, D. G., & Pessayre, D. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90190-0 · Cited by 74
Berson, A., Renault, S., Lettéron, P., Robin, M., Fromenty, B., Fau, D., Bot, M. A. L., Riché, C., Durand‐Schneider, A., Feldmann, G., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964414 · Cited by 74
Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase
Martin, J. L., Kenna, J. G., Martin, B. M., Thomassen, D. G., Reed, G. F., & Pohl, L. R. (1993) · Hepatology · doi:10.1002/hep.1840180417 · Cited by 74
Horikawa, M., Kato, Y., & Sugiyama, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1020358910490 · Cited by 73
Protein degradation by ERp72 from rat and mouse liver endoplasmic reticulum.
Urade, R., Takenaka, Y., & Kito, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80640-1 · Cited by 73
Martin, J. L., Pumford, N. R., LaRosa, A., Martin, B. M., Gonzaga, H. M. S., Beaven, M. A., & Pohl, L. R. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)90161-y · Cited by 73
Hansen, J. M., Harris, K. K., Philbert, M. A., & Harris, C. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.768 · Cited by 73
Variability of acetaminophen metabolism in Caucasians and Orientals
Patel, M., Tang, B., & KALOW, W. (1992) · Pharmacogenetics · doi:10.1097/00008571-199202000-00007 · Cited by 73
Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolites
Zhao, X.-J., Jones, D. R., Wang, Y.-H., Grimm, S. W., & Hall, S. D. (2002) · Xenobiotica · doi:10.1080/00498250210158230 · Cited by 73
Jurima‐Romet, M., Abbott, F. S., Tang, W., Huang, H. S., & Whitehouse, L. W. (1996) · Toxicology · doi:10.1016/0300-483x(96)03352-5 · Cited by 73
Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19*
Donahue, S., Flockhart, D. A., Abernethy, D. R., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90054-0 · Cited by 73
Probenecid Inhibits the Metabolic and Renal Clearances of Zidovudine (AZT) in Human Volunteers
Hedaya, M. A., Elmquist, W. F., & Sawchuk, R. J. (1990) · Pharmaceutical Research · doi:10.1023/a:1015835826114 · Cited by 72
Dansette, P. M., Amar, C., Valadon, P., Pons, C., Beaune, P. H., & Mansuy, D. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90627-h · Cited by 72
Karplus, P. A., Krauth‐Siegel, R. L., Schirmer, R. H., & Schulz, G. E. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb13775.x · Cited by 72
Liu, L., & Wells, P. G. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00082-9 · Cited by 72
Fang, J., McKay, G., Song, J., et al. (2001) · PubMed · Cited by 72
Forsman, A., & Larsson, M. (1978) · Cited by 72
Lai, W., ZAHID, N. D., & Uetrecht, J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35100-6 · Cited by 71
Usuki, E., Pearce, R. E., Parkinson, A., & Castagnoli, N. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960001y · Cited by 71
Kent, U. M., Mills, D. E., Rajnarayanan, R. V., Alworth, W. L., & Hollenberg, P. F. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.549 · Cited by 71
Dehal, S. S., & Kupfer, D. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15305-6 · Cited by 71
Kenna, J. G., Martin, J. L., Satoh, H., & Pohl, L. R. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08653-2 · Cited by 71
Anderson, N. L. (1992) · Fundamental and Applied Toxicology · doi:10.1016/0272-0590(92)90116-y · Cited by 70
Reactive metabolites and their role in drug reactions
Naisbitt, D. J., Williams, D. P., Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (2001) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200108000-00007 · Cited by 70
Diclofenac-Induced Inactivation of CYP3A4 and Its Stimulation by Quinidine
Masubuchi, Y., Ose, A., & Horie, T. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.10.1143 · Cited by 70
The Relationship Between the Disposition and Immunogenicity of Sulfamethoxazole in the Rat
Gill, H., Hough, S. J., Naisbitt, D. J., Maggs, J. L., Kitteringham, N. R., Pirmohamed, M., & Park, B. K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36867-3 · Cited by 69
Potential Metabolic Bioactivation Pathways Involving Cyclic Tertiary Amines and Azaarenes
Castagnoli, N. J., Rimoldi, J. M., Bloomquist, J., & Castagnoli, K. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970096j · Cited by 69
Korsmeyer, K. K., Davoll, S. H., Figueiredo-Pereira, M. E., & Correia, M. A. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1138 · Cited by 69
Haptenation of Sulfonamide Reactive Metabolites to Cellular Proteins
Manchanda, T., Hess, D. A., Dale, L., Ferguson, S. S. G., & Rieder, M. J. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1011 · Cited by 69
Teratogen metabolism: Thalidomide activation is mediated by cytochrome P-450
Braun, A. G., Harding, F., & Weinreb, S. L. (1986) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(86)90449-7 · Cited by 68
Effect of Tamoxifen on the Enzymatic Activity of Human Cytochrome CYP2B6
Sridar, C., Kent, U. M., Notley, L. M., Gillam, E. M. J., & Hollenberg, P. F. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.945 · Cited by 68
Sensitivity to nonsteroidal anti-inflammatory drugs
Namazy, J. A., & Simon, R. A. (2002) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62099-6 · Cited by 67
Teo, S. K., Sabourin, P. J., O'Brien, K., Kook, K. A., & Thomas, S. D. (2000) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/(sici)1099-0461(2000)14:3<140::aid-jbt3>3.0.co;2-p · Cited by 67
Bailey, M., & DICKINSON, R. G. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960017o · Cited by 67
Komatsu, T., Yamazaki, H., Asahi, S., Gillam, E. M. J., Guengerich, F. P., Nakajima, M., & Yokoi, T. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15085-4 · Cited by 67
Teratogenicity of diphenylhydantoin in the New Zealand white rabbit
McClain, R. M., & Langhoff, L. (1980) · Teratology · doi:10.1002/tera.1420210315 · Cited by 66
Effects of nimesulide and its reduced metabolite on mitochondria
Mingatto, F. E., dos Santos, A. C., Rodrigues, T., Pigoso, A. A., Uyemura, S. A., & Curti, C. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703667 · Cited by 66
Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine
Cribb, A. E., & Spielberg, S. P. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08652-0 · Cited by 65
The pharmacogenetics of NAT: structural aspects
Pompeo, F., Brooke, E., Kawamura, A., Mushtaq, A., & Sim, E. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.1.19 · Cited by 64
Fulminant Exacerbation of Autoimmune Hepatitis After the Use of Ma Huang
Borum, M. L. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03827.x · Cited by 64
Hukkanen, J., Mäntylä, M., Kangas, L., Wirta, P., Hakkola, J., Paakki, P., Evisalmi, S., Pelkonen, O., & Raunio, H. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01404.x · Cited by 64
Kostrzewa, R. M., Kostrzewa, J. P., & Brus, R. (2002) · Amino Acids · doi:10.1007/s00726-001-0110-x · Cited by 64
Phenobarbital-valproic acid interaction
Patel, I. H., Levy, R. H., & Cutler, R. E. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.72 · Cited by 64
Studies on the beta-oxidation of valproic acid in rat liver mitochondrial preparations.
Bjorge, S. M., & Baillie, T. A. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08901-9 · Cited by 63
Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin
Wolkenstein, P., Tan, C., Lecoeur, S., Wechsler, J., Garcia-Martin, N., Charue, D., Bagot, M., & Beaune, P. H. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(98)00021-0 · Cited by 63
Glutamate Dehydrogenase Covalently Binds to a Reactive Metabolite of Acetaminophen
Halmes, N. C., Hinson, J., Martin, B. M., & Pumford, N. R. (1996) · Chemical Research in Toxicology · doi:10.1021/tx950158a · Cited by 63
CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity
Neuman, M. G., Shear, N. H., Jacobson-Brown, P., Katz, G. G., Neilson, H. K., Malkiewicz, I. M., Cameron, R., & Abbott, F. S. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00217-x · Cited by 63
Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis
Węsierska‐Gądek, J., Grimm, R., Hitchman, E., & Penner, E. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70485-8 · Cited by 63
Biotransformation of xenobiotics by amine oxidases
Benedetti, M. S. (2001) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2001.00011.x · Cited by 63
Greco, A., Ajmone‐Cat, M. A., Nicolini, A., Sciulli, M. G., & Minghetti, L. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10543 · Cited by 63
Liu, Z. C., & Uetrecht, J. P. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15339-1 · Cited by 63
Castot, A., & Larrey, D. G. (1992) · PubMed · Cited by 63
Woolf, T. F., Pool, W. F., Bjorge, S. M., Chang, T., Goel, O. P., Purchase, C. F., Schroeder, M. C., Kunze, K. L., & Trager, W. F. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08177-2 · Cited by 63
Covalent Binding of Acetaminophen to N-10-Formyl-Tetrahydrofolate Dehydrogenase in Mice
Pumford, N. R., Halmes, N. C., Martin, B. M., Cook, R. J., Wagner, C., & Hinson, J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36418-3 · Cited by 62
Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus
Walchner, M., md, Meurer, M., md, Plewig, G., md, Messer, G., & md (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00866.x · Cited by 62
Ware, J. A., Graf, M. L. M., Martin, B. M., Lustberg, L. R., & Pohl, L. R. (1998) · Chemical Research in Toxicology · doi:10.1021/tx970182j · Cited by 62
Marks, M. G., Shi, J., Fry, M. O., Xiao, Z., Trzyna, M., Pokala, V. N., Ihnat, M. A., & Li, P. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.597 · Cited by 62
Pelkonen, O., Myllynen, P. K., Taavitsainen, P., Boobis, A. R., Watts, P. S., Lake, B. G., Price, R. J., Renwick, A. B., Gómez‐Lechón, M. J., Castell, J. V., et al. (2001) · Xenobiotica · doi:10.1080/00498250110055479 · Cited by 61
Kalgutkar, A. S. S., Taylor, T. J., Venkatakrishnan, K., & Isin, E. M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.3.243 · Cited by 61
Mieli‐Vergani, G. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92585-0 · Cited by 60
Human Flavin-Containing Monooxygenase (form 3): Polymorphisms and Variations In Chemical Metabolism
Cashman, J. R. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.3.325 · Cited by 60
Epitope mapping studies with human anti-cytochrome P450 3A antibodies.
Leeder, J. S., Gaedigk, A., Lu, X., & Cook, V. A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08704-8 · Cited by 60
Identification of glutathione conjugates of troglitazone in human hepatocytes
Prabhu, S., Fackett, A., Lloyd, S., McClellan, H., Terrell, C. M., Silber, P. M., & Li, A. P. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00056-x · Cited by 59
Wheeler, C., Berry, S., Wilkins, M. R., Corbett, J. M., Ou, K., Gooley, A. A., Humphery‐Smith, I., Williams, K. L., & Dunn, M. J. (1996) · Electrophoresis · doi:10.1002/elps.1150170329 · Cited by 59
Oxidation of Tienilic Acid by Human Yeast‐Expressed Cytochromes P‐450 2C8, 2C9, 2C18 and 2C19
Jean, P., Lopez‐Garcia, P., Dansette, P. M., Mansuy, D., & Goldstein, J. A. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00797.x · Cited by 58
Butler, L. E., Thomassen, D. G., Martin, J. L., Martin, B. M., Kenna, J. G., & Pohl, L. R. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00027a014 · Cited by 58
Trivier, J.-M., Libersa, C., Belloc, C., & Lhermitte, M. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90523-6 · Cited by 58
Reilly, T., Woster, P. M., & Svensson, C. K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38046-2 · Cited by 57
Interindividual Variability in Human Drug Metabolism
Pacifici, G. M., & Pelkonen, O. (2001) · CRC Press eBooks · doi:10.1201/9781482289220 · Cited by 56
Gupta, S., Rogers, L. K., Tasian, S. K., & Smith, C. V. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8228 · Cited by 56
Morgan, K. T., Ni, H., Brown, H. R., Yoon, L. W., Qualls, C. W., Crosby, L. M., Reynolds, R. P., Gaskill, B., Anderson, S. P., Kepler, T. B., et al. (2002) · Toxicologic Pathology · doi:10.1080/01926230290105613 · Cited by 56
Nolan, C. M., GOLDBERG, S. V., & BUSKLN, S. E. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00058 · Cited by 56
Valproic acid and diazepam interaction in vivo.
Dhillon, S., & Richens, A. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb01421.x · Cited by 55
Polymeros, D., Kamberoglou, D. K., & Tzias, V. D. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200201000-00022 · Cited by 55
Sinclair, J. F., Jeffery, E. H., Wrighton, S. A., et al. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00656-4 · Cited by 54
Role of CYP3A in Ethanol-Mediated Increases in Acetaminophen Hepatotoxicity
Kostrubsky, V. E., Szakacs, J. G., Jeffery, E. H., Wood, S. G., Bement, W. J., Wrighton, S. A., Sinclair, P. R., & Sinclair, J. F. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8081 · Cited by 54
Cited by
Bruderer, R., Bernhardt, O. M., Gandhi, T., Miladinović, S. M., Cheng, L.-Y., Messner, S., Ehrenberger, T., Zanotelli, V., Butscheid, Y., Escher, C., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.044305 · Cited by 1,238
Tiwari, B., Sellamuthu, B., Ouarda, Y., Drogui, P., Tyagi, R. D., & Buelna, G. (2017) · Bioresource Technology · doi:10.1016/j.biortech.2016.11.042 · Cited by 817
Targeted Covalent Inhibitors for Drug Design
Baillie, T. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601091 · Cited by 578
Apparent activity in high-throughput screening: origins of compound-dependent assay interference
Thorne, N., Auld, D. S., & Inglese, J. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.020 · Cited by 430
Strategies for Discovering and Derisking Covalent, Irreversible Enzyme Inhibitors
Johnson, D. S., Weerapana, E., & Cravatt, B. F. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.21 · Cited by 387
Metadata
- Authors
- Zhou, S., Chan, E., Duan, W., Huang, M., & Chen, Y.-Z.
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2005-01
- Volume
- 37
- Issue
- 1
- Pages
- 41-213
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W1997486990
- Cited by
- 274
- References
- 774
- FWCI
- 13.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.